Related Experiment Video
Updated: Sep 15, 2025

An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
Formulation and evaluation of safe and effective polyherbal antidiabetic drug
Iqra Kanwal1, Nudrat Fatima1, Ambreen Huma1
1Department of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, Ziauddin University, Karachi.
None:
Diabetes is a commonly spreading disease in the world with Pakistan having prevalence levels of 30% approximately. The objective of this research study is to manage the growing problem of increasing diabetic levels in Pakistani population with a safe and effective herbal remedy, as the synthetic anti-diabetic medicines are generating intolerable side effects which could be reduced by this study outcome. Four plants i.e. Fagonia arabica, Moringa oleifera, Nigella sativa and Trigonella foenum-graecum were selected for formulation. The raw material was obtained from certified suppliers and underwent quality testing using standardized methods, then thoroughly mixed in the best combination and filled using capsule filling machine. The capsules were then tested for quality through phytochemical, physicochemical and phytopharmaceutical testing, FTIR assay, weight variation and disintegration test following standard methods. The safety was tested via acute oral toxicity test, while efficacy was tested through oral glucose tolerance test and anti-diabetic assay. The result indicated that the newly formulated capsules are effective against high blood sugar levels, comply with the pharmacopeial standards, and are safe enough as an oral drug. Further work on stability testing and toxicological studies are in progress which upon successful completion will open doors for clinical trials.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Glinides
Oral Hypoglycemic Agents: Sulfonylureas
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

